⌘K

Login Start Free

Home/Filings/4/0001493152-22-024234

4//SEC Filing

Trieu Vuong 4

Accession 0001493152-22-024234

CIK 0000908259other

View on SEC.gov Company Profile

Filed

Aug 28, 8:00 PM ET

Accepted

Aug 29, 9:15 AM ET

Size

6.1 KB

Accession

0001493152-22-024234

Insider Transaction Report

Form 4

Period: 2022-08-25

Oncotelic Therapeutics, Inc.OTLC

DirectorCHAIRMAN AND CEO10% Owner

Transactions

Purchase
Common Stock
2022-08-25$0.08/sh+80,000$6,560→ 90,348,021 total

Holdings

Common Stock
(indirect: By Spouse)
6,872,529
Common Stock
(indirect: By Autotelic, Inc.)
16,780,384

Documents

1 file

4
ownership.xmlPrimary

Issuer

Oncotelic Therapeutics, Inc.

CIK 0000908259

Entity typeother

Related Parties

1

filerCIK 0001587074

Filing Metadata

Form type: 4
Filed: Aug 28, 8:00 PM ET
Accepted: Aug 29, 9:15 AM ET
Size: 6.1 KB

View on SEC.gov